The Future of Life Sciences: Can Biotech Bounce Back?
May 16 @ 8:30 am - 11:00 am
Don’t miss your chance to hear from leading Life Science and CRE experts about the state of the industry and development in Philadelphia.
Agenda:
-
- 8:30-9:15am: Breakfast & Networking
- 9:15-10am: Panel 1 with Reporter Paul Schwedelson
- 10-11am: Panel 2 with Senior Reporter John George
Panel 1: After developers rushed to build new lab space, tenant demand and new development has slowed down. What does that mean for the future of Philadelphia’s life sciences sector and how will real estate developers respond?
Moderated by Reporter Paul Schwedelson
- Nelson Way, director of leasing and development, Ensemble Real Estate Investments
- Anne Cummins, co-founder and chief operating office, Gattuso Development Partners
- Pete Cramer, vice president and market executive, Wexford Science + Technology
- Jeff DeVuono, executive vice president, life science division, Brandywine Realty Trust
Panel 2: The Cellicon Valley Scene: State of the life sciences industry
Moderated by Senior Reporter John George
- William Chou, M.D., CEO of Passage Bio
- Bruce Levine, Professor of gene therapy, University of Pennsylvania, co-founder of Capstan Therapeutics
- Tiffany Wilson, president and CEO of the University City Science Center
- Lorenzo Pellegrini, managing partner of the Hatch Biofund
- Heather A. Steinman, Ph.D., MBA, Senior Vice President for Business Development and Executive Director of Technology Transfer, The Wistar Institute
